Should clinical trial research of psychotropic medication in autism control for gastrointestinal symptoms?
Recent research has established that many children and adult diagnosed with autism experience gastrointestinal symptoms. Furthermore, research has demonstrated that gastrointestinal symptoms can impact drug availability and absorption. In this paper we explore the presence of gastrointestinal symptoms in autism and put forth a call for a formal evaluation of the potential relationship between gastrointestinal symptoms and psychotropic medication effectiveness in individuals with autism.
Department of Psychology, Drake University, Des Moines, IA, USA.
Andrew M
AM
Heitzer
Meredith A
MA
Job
Nivedita K
NK
Pandit
Maria G
MG
Valdovinos
D000328:Adult; D001321:Autistic Disorder / Q000150:complications / Q000188:drug therapy*; D002648:Child; D002986:Clinical Trials as Topic / Q000379:methods; D005767:Gastrointestinal Diseases / Q000209:etiology / Q000503:physiopathology*; D006801:Humans; D011619:Psychotropic Drugs / Q000493:pharmacokinetics / Q000627:therapeutic use*
D011619:Psychotropic Drugs
autism; gastrointestinal symptoms; psychotropic medication